Loading clinical trials...
Loading clinical trials...
A Phase II Study of PS-341 Alone or in Combination With Irinotecan in Patients With Adenocarcinoma of the Gastroesophageal Junction (GEJ) or Stomach
Conditions
Interventions
bortezomib
irinotecan
Locations
1
United States
Montefiore Medical Center
The Bronx, New York, United States
Start Date
April 1, 2003
Primary Completion Date
December 1, 2009
Completion Date
November 1, 2013
Last Updated
February 2, 2021
NCT06881017
NCT01939275
NCT02065765
NCT02443324
NCT04773769
NCT01107639
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions